TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Bioconnect AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,020
|
876
|
823 |
Financial expenses |
8
|
9
|
7 |
Earnings before taxes |
2,525
|
210
|
133 |
Total assets |
2,930
|
440
|
282 |
Current assets |
2,867
|
395
|
228 |
Current liabilities |
1,229
|
138
|
134 |
Equity capital |
1,700
|
302
|
147 |
- share capital |
9
![]() |
9
|
10 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
58.0%
|
68.6%
|
52.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
247.5%
|
24.0%
|
16.2% |
Return on assets (ROA) |
86.5%
|
49.8%
|
49.6% |
Current ratio |
233.3%
|
286.2%
|
170.1% |
Return on equity (ROE) |
148.5%
|
69.5%
|
90.5% |
Change turnover |
199
|
97
|
-192 |
Change turnover % |
24%
|
12%
|
-19% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.